Jay A. Fishman, M.D. is Professor of Medicine at Harvard Medical School, Director of the Transplant Infectious Diseases and Compromised Host Program at the Massachusetts General Hospital (MGH), and Associate Director of the MGH Transplant Center. Dr. Fishman completed medical school at Johns Hopkins University School of Medicine, internal medicine training and Infectious Disease Fellowship at MGH, and Fellowships in Molecular Biology and Genetics at MGH and Harvard Medical School. Dr. Fishman established the Transplant and Immunocompromised Host Program of the MGH, the first such training program worldwide which has trained many leaders in this field. He established Transplant Infectious Disease as an essential component of Transplant programs and developed the first curriculum for the field. His clinical expertise spans infectious diseases of solid organ and stem cell transplant recipients and other immunocompromised hosts. His studies defined the use of ganciclovir for cytomegalovirus infection in clinical trials in transplant recipients. His training in immunology, virology and molecular biology provides a foundation for studies of infections in xenotransplantation and viral pathogenesis in transplantation. His lab cloned the major surface antigens of human Pneumocystis and porcine endogenous retrovirus from normal pig cells to investigate this potential pathogen in xenotransplantation. He has shared his expertise with clinicians worldwide through lectures and thorough over 300 peer-reviewed publications. Dr. Fishman is a Fellow of the American College of Physicians, the American Society of Transplantation, and the Infectious Disease Society of America. He is a frequent contributor at international symposia. He is Past-President of the American Society of Transplantation. He is current on the Board of the International Xenotransplantation Association and chairs the Infectious Disease Committee of IXA. He has received career achievement awards from AST and TTS.
09:35 - 10:35
|Mini-Oral Abstract Session — Miscellaneous topics 2
08:00 - 09:30
|Oral Abstract Session — Monitoring pre-clinical and clinical application of xenotransplantation